South Texas Institute of Cancer is a clinical research site located in Corpus Christi, Texas, United States 78405.
Crixeo Health Trust Score: 69/100 (FAIR). This profile has not yet been claimed by the site owner.
South Texas Institute of Cancer has participated in 6 clinical trials.
Therapeutic areas: Chronic Myelogenous Leukemia - Chronic Phase, Breast Cancer, Chronic Lymphocytic Leukemia.
Sponsors: Novartis Pharmaceuticals, Eisai Inc., Celgene.
Trust Score: 69/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
South Texas Institute of Cancer has a Crixeo Trust Score of 69/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
South Texas Institute of Cancer has 6 clinical trials on record. Their work covers Chronic Myelogenous Leukemia - Chronic Phase, Breast Cancer, Chronic Lymphocytic Leukemia.
South Texas Institute of Cancer has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.